US Congress Senate Bill 4199 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 11-0)
Status: Introduced on July 2 2020 - 25% progression, died in committee
Action: 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Alters several programs and requirements relating to the prices of prescription drugs under Medicare and Medicaid. Among other things, the bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for certain drugs covered under Medicare for which the average manufacturer price increases faster than inflation; requires drug manufacturers to issue rebates to the CMS for discarded amounts of certain single-dose drugs covered under Medicare, based on information reported by providers; reduces the annual out-of-pocket spending threshold, and eliminates beneficiary cost-sharing above this threshold, under the Medicare prescription drug benefit; requires the CMS to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and increases the maximum rebate payable by drug manufacturers under the Medicaid Drug Rebate Program.

Prescription Drug Pricing Reduction Act of 2020

Sen. Chuck Grassley [R-IA]	Sen. Rob Portman [R-OH]	Sen. Bill Cassidy [R-LA]	Sen. Steve Daines [R-MT]
Sen. Susan Collins [R-ME]	Sen. Joni Ernst [R-IA]	Sen. Martha McSally [R-AZ]	Sen. Mike Braun [R-IN]
Sen. Cindy Hyde-Smith [R-MS]	Sen. Lisa Murkowski [R-AK]	Sen. Dan Sullivan [R-AK]

Date	Chamber	Action
2020-07-02	Senate	Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)

HB1264 (Related) 2019-02-15 - Referred to the Subcommittee on Health.
HB1781 (Related) 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
HB3029 (Related) 2019-06-04 - Subcommittee Hearings Held.
HB4629 (Related) 2019-10-18 - Sponsor introductory remarks on measure. (CR H8232)
HB4649 (Related) 2019-10-30 - Sponsor introductory remarks on measure. (CR H8607)
HB5281 (Related) 2019-12-04 - Referred to the Subcommittee on Health.
HB5882 (Related) 2020-02-12 - Referred to the House Committee on Energy and Commerce.
SB801 (Related) 2019-03-14 - Read twice and referred to the Committee on Finance.
SB1505 (Related) 2019-05-16 - Read twice and referred to the Committee on Finance.
SB1999 (Related) 2019-06-27 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/senate-bill/4199/all-info
Text	https://www.congress.gov/116/bills/s4199/BILLS-116s4199is.pdf